MRFAP1L1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.850400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.771400E-01
Normal-vs-Stage2
1.939820E-01
Normal-vs-Stage3
7.889800E-02
Normal-vs-Stage4
4.386600E-01
Stage1-vs-Stage2
3.712800E-01
Stage1-vs-Stage3
5.178200E-02
Stage1-vs-Stage4
6.372000E-01
Stage2-vs-Stage3
2.296000E-01
Stage2-vs-Stage4
8.264400E-01
Stage3-vs-Stage4
3.544800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.716400E-01
Normal-vs-AfricanAmerican
5.634000E-01
Normal-vs-Asian
4.491400E-01
Caucasian-vs-AfricanAmerican
5.557600E-01
Caucasian-vs-Asian
9.346000E-01
AfricanAmerican-vs-Asian
7.231000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.638600E-01
Normal-vs-Female
3.270200E-01
Male-vs-Female
2.376800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.481000E-01
Normal-vs-Age(41-60Yrs)
4.887800E-01
Normal-vs-Age(61-80Yrs)
2.373000E-01
Normal-vs-Age(81-100Yrs)
7.630200E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.518400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.832000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.695000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.684200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.792420E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.706200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.152400E-02
Normal-vs-Daily Drinker
4.786200E-01
Normal-vs-Weekly Drinker
1.328610E-01
Normal-vs-Occasional Drinker
4.937600E-01
Normal-vs-Social Drinker
2.530000E-01
Non Drinker-vs-Daily Drinker
1.806010E-01
Non Drinker-vs-Weekly Drinker
9.128200E-01
Non Drinker-vs-Occasional Drinker
2.964400E-02
Non Drinker-vs-Social Drinker
3.435600E-01
Daily Drinker-vs-Weekly Drinker
2.791800E-01
Daily Drinker-vs-Occasional Drinker
6.126000E-01
Daily Drinker-vs-Social Drinker
7.266000E-01
Weekly Drinker-vs-Occasional Drinker
6.932400E-02
Weekly Drinker-vs-Social Drinker
4.015800E-01
Occasional Drinker-vs-Social Drinker
3.205400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.345200E-01
Normal-vs-Grade 2
7.651600E-01
Normal-vs-Grade 3
7.507200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.709400E-01
Grade 1-vs-Grade 3
5.964800E-01
Grade 1-vs-Grade 4
4.345200E-01
Grade 2-vs-Grade 3
7.116400E-01
Grade 2-vs-Grade 4
7.651600E-01
Grade 3-vs-Grade 4
7.507200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.354010E-01
Normal-vs-NonDiabetic
3.437000E-01
Diabetic-vs-NonDiabetic
2.514600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.669420E-01
Normal-vs-NoPancreatitis
2.679800E-01
Pancreatitis-vs-NoPancreatitis
7.600000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.549600E-01
Normal-vs-N1
2.344200E-01
N0-vs-N1
3.857000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.984400E-01
Normal-vs-TP53-NonMutant
6.095000E-01
TP53-Mutant-vs-TP53-NonMutant
6.436600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
